# Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study)

> **NCT01185977** · PHASE4 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 26 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Fluoxetine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01185977
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-10
- **Final completion:** —
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01185977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01185977, "Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01185977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*